Literature DB >> 16877050

Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results.

Lutz Goldbeck1, Sven Zerrer, Tim G Schmitz.   

Abstract

BACKGROUND: To investigate the feasibility of monitoring quality of life (QL) with cystic fibrosis (CF) in a clinical setting, to explore changes in subjective health and to describe the impact of multiple medical and psychosocial factors on the patients' QL.
METHODS: 108 adolescent and adult outpatients (age 15-47 years, FEV(1) 20-125% of the predicted) answered the Questions on Life Satisfaction repeatedly parallel to each pulmonary function test (2-16 assessments per patient within 18 months). Multiple regression analysis determined the contribution of medical and psychosocial factors to the patients' QL.
RESULTS: Good acceptance of the instrument was observed. The completion time was between 5 and 29 min per assessment (median 11 min). QL remained quite stable (r(tt)=.69) with the previous QL score predicting most of the variance of the present score. Additionally, a longer interval between assessments, new colonization with Pseudomonas aeruginosa, infection exacerbations, partnership, vocation and living separately from parents significantly predicted QL at the second assessment. Pulmonary function varied independently of QL.
CONCLUSIONS: Medical factors such as pulmonary exacerbation and social living circumstances have an impact on the QL of patients with CF. Repeated QL assessments in clinical routine are feasible and useful to recognize the individual patient's adaptation to the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16877050     DOI: 10.1016/j.jcf.2006.06.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

1.  Growing up with cystic fibrosis: achievement, life satisfaction, and mental health.

Authors:  Tanja Besier; Lutz Goldbeck
Journal:  Qual Life Res       Date:  2012-01-04       Impact factor: 4.147

2.  Longitudinal trends in health-related quality of life in adults with cystic fibrosis.

Authors:  Edward J Dill; Ree Dawson; Deborah E Sellers; Walter M Robinson; Gregory S Sawicki
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

3.  Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.

Authors:  Abdul Ashish; Matthew Shaw; James McShane; Martin J Ledson; Martin J Walshaw
Journal:  JRSM Short Rep       Date:  2012-02-27

4.  Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis.

Authors:  Janice Abbott; Alison M Morton; Margaret A Hurley; Steven P Conway
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

5.  Chronic inflammation and quality of life in older adults: a cross-sectional study using biomarkers to predict emotional and relational outcomes.

Authors:  Alexandra C H Nowakowski
Journal:  Health Qual Life Outcomes       Date:  2014-09-28       Impact factor: 3.186

6.  Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period.

Authors:  Grażyna Dębska; Henryk Mazurek
Journal:  Patient Prefer Adherence       Date:  2015-12-15       Impact factor: 2.711

7.  Associations between genetics, medical status, physical exercise and psychological well-being in adults with cystic fibrosis.

Authors:  Lena Backström-Eriksson; Agneta Bergsten-Brucefors; Lena Hjelte; Bo Melin; Kimmo Sorjonen
Journal:  BMJ Open Respir Res       Date:  2016-11-07

8.  The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

Authors:  Anthony A Fodor; Erich R Klem; Deirdre F Gilpin; J Stuart Elborn; Richard C Boucher; Michael M Tunney; Matthew C Wolfgang
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

9.  Qulaity of life in cystic fibrosis children.

Authors:  Hamid-Reza Kianifar; Banafsheh Bakhshoodeh; Paria Hebrani; Fatemeh Behdani
Journal:  Iran J Pediatr       Date:  2013-04       Impact factor: 0.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.